Page 869 - Saunders Comprehensive Review For NCLEX-RN
P. 869

3. Adverse effects and contraindications
                                                             a. Can cause headache, nausea, vomiting,
                                                                diarrhea, fever, tachycardia, and
                                                                hypertension
                                                             b. Contraindicated if the client has asthma
                                             4. Interventions
                                                             a. Monitor vital signs.
                                                             b. Monitor vaginal bleeding and uterine
                                                                tone.
                                C. Oxytocin: See Section VI on uterine stimulants.
                    VIII. Rh (D) Immune Globulin
                             o
                                A. Description
                                             1. Prevention of anti-Rh (D) antibody formation is most
                                                                      o
                                                successful if the medication is administered twice, at
                                                28 weeks’ gestation and again within 72 hours after
                                                delivery.

                                                      2. Rh (D) immune globulin also should be
                                                           o
                                                administered within 72 hours after potential or actual
                                                exposure to Rh-positive blood and must be given
                                                with each subsequent exposure or potential exposure
                                                to Rh-positive blood.
                                B. Use: To prevent isoimmunization in Rh-negative clients who are
                                   negative for Rh antibodies and exposed or potentially exposed to
                                   Rh-positive red blood cells by amniocentesis, chorionic villus
                                   sampling, transfusion, termination of pregnancy, abdominal
                                   trauma, or bleeding during pregnancy or the birth process
                                C. Adverse effects and contraindications
                                             1. Elevated temperature
                                             2. Tenderness at the injection site
                                             3. Contraindicated for Rh-positive clients
                                             4. Contraindicated in clients with a history of systemic
                                                allergic reactions to preparations containing human
                                                immunoglobulins
                                             5. Note: Not administered to a newborn
                                        D. Interventions


                                             1. Administer to the client by intramuscular injection at
                                                28 weeks’ gestation and within 72 hours after
                                                delivery.
                                             2. Never administer by the IV route.
                                             3. Monitor for temperature elevation.
                                             4. Monitor injection site for tenderness.



                                                       Rh (D) immune globulin is of no benefit when the client has
                                                          o
                                                developed a positive antibody titer to the Rh antigen.


                                                          869
   864   865   866   867   868   869   870   871   872   873   874